DK171110B1 - Fremgangsmåde til fremstilling af 5-methyl-3-(2-pyridyl)-2H,5H-1,3-oxazino(5,6-c)-1,2-benzothiazin-2,4-(3H)-dion-6,6-dioxid eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Fremgangsmåde til fremstilling af 5-methyl-3-(2-pyridyl)-2H,5H-1,3-oxazino(5,6-c)-1,2-benzothiazin-2,4-(3H)-dion-6,6-dioxid eller farmaceutisk acceptable syreadditionssalte deraf Download PDF

Info

Publication number
DK171110B1
DK171110B1 DK274185A DK274185A DK171110B1 DK 171110 B1 DK171110 B1 DK 171110B1 DK 274185 A DK274185 A DK 274185A DK 274185 A DK274185 A DK 274185A DK 171110 B1 DK171110 B1 DK 171110B1
Authority
DK
Denmark
Prior art keywords
formula
compound
methyl
dioxide
benzothiazine
Prior art date
Application number
DK274185A
Other languages
Danish (da)
English (en)
Other versions
DK274185A (da
DK274185D0 (da
Inventor
Joseph George Lombardino
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK274185D0 publication Critical patent/DK274185D0/da
Publication of DK274185A publication Critical patent/DK274185A/da
Application granted granted Critical
Publication of DK171110B1 publication Critical patent/DK171110B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK274185A 1984-06-21 1985-06-18 Fremgangsmåde til fremstilling af 5-methyl-3-(2-pyridyl)-2H,5H-1,3-oxazino(5,6-c)-1,2-benzothiazin-2,4-(3H)-dion-6,6-dioxid eller farmaceutisk acceptable syreadditionssalte deraf DK171110B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/623,251 US4656265A (en) 1984-06-21 1984-06-21 Cyclic prodrugs of antiinflammatory oxicams
US62325184 1984-06-21

Publications (3)

Publication Number Publication Date
DK274185D0 DK274185D0 (da) 1985-06-18
DK274185A DK274185A (da) 1985-12-22
DK171110B1 true DK171110B1 (da) 1996-06-17

Family

ID=24497355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK274185A DK171110B1 (da) 1984-06-21 1985-06-18 Fremgangsmåde til fremstilling af 5-methyl-3-(2-pyridyl)-2H,5H-1,3-oxazino(5,6-c)-1,2-benzothiazin-2,4-(3H)-dion-6,6-dioxid eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (29)

Country Link
US (1) US4656265A (de)
JP (1) JPS6112692A (de)
KR (1) KR870000627B1 (de)
AT (1) AT393269B (de)
AU (1) AU556117B2 (de)
BE (1) BE902682A (de)
CA (1) CA1234813A (de)
CH (1) CH664157A5 (de)
DE (1) DE3521722A1 (de)
DK (1) DK171110B1 (de)
EG (1) EG17534A (de)
ES (1) ES8609333A1 (de)
FI (1) FI852461L (de)
FR (1) FR2566408B1 (de)
GB (1) GB2160523B (de)
GR (1) GR851489B (de)
HU (1) HU196214B (de)
IE (1) IE58135B1 (de)
IL (1) IL75566A (de)
IT (1) IT1190373B (de)
LU (1) LU85961A1 (de)
NL (1) NL193192C (de)
NO (1) NO171727C (de)
NZ (1) NZ212476A (de)
PH (1) PH20816A (de)
PL (1) PL146350B1 (de)
PT (1) PT80664B (de)
SE (1) SE456995B (de)
ZA (1) ZA854649B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656265A (en) * 1984-06-21 1987-04-07 Pfizer Inc. Cyclic prodrugs of antiinflammatory oxicams
FR2597103B1 (fr) * 1986-04-15 1988-12-16 Provesan Sa Procede de preparation de derives d'oxazinobenzothiazine 6,6-dioxyde
WO1990011763A1 (en) * 1989-04-06 1990-10-18 Pfizer Inc. N-ALKENYLBENZO[b]THIENO[3,2-b]OXAZIN-2,4-DIONES
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3492298A (en) * 1968-02-21 1970-01-27 Mcneilab Inc Oxazino-benzothiazine-6,6-dioxides
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3923801A (en) * 1974-09-23 1975-12-02 Mcneilab Inc Oxazinobenzothiazine 6,6-dioxides
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
US4309427A (en) * 1981-01-15 1982-01-05 Pfizer Inc. Benzothiazine dioxide derivatives
FR2528433A1 (fr) * 1982-06-15 1983-12-16 Provesan Sa Nouveaux derives d'oxazinobenzothiazine-6,6-dioxyde, leur preparation et leur application en tant que medicaments
US4656265A (en) * 1984-06-21 1987-04-07 Pfizer Inc. Cyclic prodrugs of antiinflammatory oxicams

Also Published As

Publication number Publication date
KR860000295A (ko) 1986-01-27
DK274185A (da) 1985-12-22
GB2160523B (en) 1988-06-22
DE3521722C2 (de) 1988-09-15
GB2160523A (en) 1985-12-24
IT1190373B (it) 1988-02-16
DK274185D0 (da) 1985-06-18
GR851489B (de) 1985-11-25
IE58135B1 (en) 1993-07-14
IL75566A (en) 1990-06-10
EG17534A (en) 1990-08-30
PT80664A (en) 1985-07-01
FR2566408B1 (fr) 1989-11-03
KR870000627B1 (ko) 1987-03-26
NL8501776A (nl) 1986-01-16
ES8609333A1 (es) 1986-07-16
BE902682A (fr) 1985-12-18
PL254117A1 (en) 1986-05-20
FI852461L (fi) 1985-12-22
NL193192C (nl) 1999-02-02
SE8503109L (sv) 1985-12-22
NZ212476A (en) 1988-08-30
FR2566408A1 (fr) 1985-12-27
US4656265A (en) 1987-04-07
IT8521218A0 (it) 1985-06-20
FI852461A0 (fi) 1985-06-20
CA1234813A (en) 1988-04-05
ZA854649B (en) 1987-02-25
PT80664B (pt) 1988-01-22
LU85961A1 (fr) 1986-01-24
PL146350B1 (en) 1989-01-31
JPS6112692A (ja) 1986-01-21
HU196214B (en) 1988-10-28
ATA180785A (de) 1991-02-15
CH664157A5 (fr) 1988-02-15
HUT44564A (en) 1988-03-28
NO171727B (no) 1993-01-18
AU556117B2 (en) 1986-10-23
ES544397A0 (es) 1986-07-16
NO171727C (no) 1993-04-28
IE851521L (en) 1985-12-21
PH20816A (en) 1987-04-24
NL193192B (nl) 1998-10-01
NO852490L (no) 1985-12-23
SE8503109D0 (sv) 1985-06-20
SE456995B (sv) 1988-11-21
AT393269B (de) 1991-09-25
JPH03874B2 (de) 1991-01-09
AU4386485A (en) 1986-01-02
DE3521722A1 (de) 1985-12-19
GB8515437D0 (en) 1985-07-17

Similar Documents

Publication Publication Date Title
US20020016322A1 (en) Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use
HU215437B (hu) Gyulladáscsökkentő és vérlemezke-aggregációt gátló salétromsav-észterek és eljárás előállításukra
AU640300B2 (en) Pharmacologically active substituted oxybenzamides
NO322309B1 (no) Indenotiazolforbindelser, legemiddel som inneholder slike forbindelser, fremgangsmate for deres fremstilling og deres anvendelse som anoreksimidler.
PT99982A (pt) Processo para a preparacao de derivados de n-hidroxi-ureia contendo um grupo oxalolilo ou tiazolilo uteis como agentes antialergicos e anti-inflamatorios
DK171110B1 (da) Fremgangsmåde til fremstilling af 5-methyl-3-(2-pyridyl)-2H,5H-1,3-oxazino(5,6-c)-1,2-benzothiazin-2,4-(3H)-dion-6,6-dioxid eller farmaceutisk acceptable syreadditionssalte deraf
NO823829L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
US3637707A (en) 2-(substituted) 2-thiazolines for the control of rice blast
US4526973A (en) Chemical compounds
EP0310109B1 (de) Aminoalkyl-substituierte, heterozyklische Schwefelverbindungen
GB1598628A (en) Guanidine derivatives
LU85780A1 (fr) Nouveaux esters enoliques precurseurs de medicaments et composition pharmaceutique les contenant
DK159112B (da) Analogifremgangsmaade til fremstilling af n-(1,3-dithiolan-2-yliden)aniliner eller farmaceutisk acceptable syreadditionssalte deraf
CA1093582A (fr) Procede d'obtention de nouvelles propylenediamines
Haworth et al. 44. Investigations on the influence of chemical constitution upon toxicity. Part I. Compounds related to “Doryl”
JPH07110848B2 (ja) チオエ−テルその製法及びこれを含有するアレルギ−性疾病治療剤
US4546188A (en) Substituted 1,2-diaminocyclobutene-3,4-diones
GB1565021A (en) Pharmaceutical compositions containing alkylamine deratives
JPS6134424B2 (de)
SU1158044A3 (ru) Способ получени 3-метил-4-хлор-5-бромэтиламинометилизоксазола или его гидрохлорида
FI95911C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-alkenyylibentso/b/tieno-/3,2-b/oksatsiini-2,4-dionien valmistamiseksi
CH632763A5 (en) Triazolothiadiazine derivatives and processes for preparing them
US5508280A (en) 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
US5217968A (en) N-alkylbenzo(b)thieno [3,2-b]oxazin-2,4-diones
FR2932480A1 (fr) Phenyl-alkyl-piperazines ayant une activite modulatrice du tnf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK